Disposition of 540000 shares by Duvall Diantha of Curis at 1.12 subject to Rule 16b-3
| CRIS Stock | USD 3.43 0.16 4.89% |
Slightly above 55% of Curis' private investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Curis Inc suggests that some traders are interested. Curis' investing sentiment can be driven by a variety of factors including economic data, Curis' earnings reports, geopolitical events, and overall market trends.
Curis |
Filed transaction by Curis Inc Officer Cfo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Curis Fundamental Analysis
We analyze Curis' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Curis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Curis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Curis is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Curis Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Curis stock to make a market-neutral strategy. Peer analysis of Curis could also be used in its relative valuation, which is a method of valuing Curis by comparing valuation metrics with similar companies.
Peers
Curis Related Equities
| MREO | Mereo BioPharma | 6.16 | ||||
| XFOR | X4 Pharmaceuticals | 6.12 | ||||
| ADAP | Adaptimmune Therapeutics | 1.75 | ||||
| ARTL | Artelo Biosciences | 1.69 | ||||
| INZY | Inozyme Pharma | 1.54 | ||||
| DAWN | Day One | 1.05 | ||||
| AFMD | Affimed NV | 0.91 | ||||
| TERN | Terns Pharmaceuticals | 0.64 | ||||
| CRVS | Corvus Pharmaceuticals | 2.57 | ||||
| LPTX | Leap Therapeutics | 4.35 | ||||
| APTO | Aptose Biosciences | 4.55 | ||||
| PDSB | PDS Biotechnology | 10.12 |
Additional Tools for Curis Stock Analysis
When running Curis' price analysis, check to measure Curis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curis is operating at the current time. Most of Curis' value examination focuses on studying past and present price action to predict the probability of Curis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curis' price. Additionally, you may evaluate how the addition of Curis to your portfolios can decrease your overall portfolio volatility.